Twilio (TWLO: $30)
Bull Market Report Target Price: $72
Bull Market Report Sell Price: $29
Earnings Date: Monday, 5:00 PM ET
Consensus: 2Q17
Revenues: $85 million
EPS: -$0.11
Year Ago Quarter Results
Revenues: $64 million
EPS: -$0.08
Key Things to Watch For in the Quarter
For 2Q17, Twilio is expected to report a 25% increase in revenues and an 11 cent loss per share. Twilio has struggled to impress investors over the past year with the stock down 30%. However the stock has recovered 20% since the beginning of the current quarter. It has found support in the $27-$30 range and will climb with the firm’s ability to consistently beat estimates into the future.
Tesoro (TSO)
Andeavor (ANDV: $98)
Bull Market Report Target Price: $110
Bull Market Report Sell Price: $78
Earnings Date: Tuesday, 4:00 PM ET
Consensus: 2Q17
Revenues: $ 8 billion
EPS: $1.58
Year Ago Quarter Results
Revenues: $6 billion
EPS: $1.64
Key Things to Watch For in the Quarter
Wall Street expects Tesoro to report 30% revenue growth and a 4% decrease in EPS for 2Q17. Despite having only beaten estimates in two of the past four quarters, the stock is still up over 25% since this time last year. The stock currently trades at a PE ratio of 16, which is relatively low compared to its industry’s PE around 30. A number of insider buy transactions from the CFO and other executives indicate confidence in the company’s long term potential.
San Antonio-based refining company Tesoro now has a new name, brand and identity. Tesoro (TSO) was officially reborn as Andeavor Corp. (ANDV: $98) during a Tuesday morning opening bell ringing ceremony at the New York Stock Exchange.
Andeavor was created following the merger of Tesoro and El Paso-based Western Refining earlier this year. The $6.4 billion deal closed in June when the newly merged company announced that it would be rebranded on Aug. 1. Andeavor President and CEO Greg Goff, who served as President and CEO of Tesoro, said that the merged company's new name reflects the progress that it has made over the last several years and the opportunities it has in the future.
We hereby raise the Sell Price from $78 to $95. We don’t want to lose the nice gain in this stock if crude heads back to $40.
Opko Health (OPK: $6.30)
Bull Market Report Target Price: $13
Bull Market Report Sell Price: $6
Earnings Date: Tuesday, 4:00 PM ET
Consensus: 2Q17
Revenues: $320 million
EPS: -$0.05
Year Ago Quarter Results
Revenues: $360 million
EPS: $0.02
Key Things to Watch For in the Quarter
Opko is expected to report a 10% decrease in revenues and a 5 cent loss per share for 2Q17. The stock has been slammed in recent quarters depreciating nearly 40% over the past year, however this has just provided investors cheaper opportunities to buy. Most industry targets including our own indicate that the stock could at least double over the long term. Part of our conviction comes from the firm’s ability to meet or beat estimates in three of the past four quarters, the main driver of most stock prices; as well as the founder continuing to buy shares.